TET2 and cancer: It is also known that TET2 mutations are among the most common in Clonal Hematopoiesis of Indeterminate Potential (CHIP), a condition where aging individuals develop hematopoietic clones without having full-blown cancer, but with an increased risk of cardiovascular disease and leukemia.